BRCA1 and breast cancer: Compared with BRCA1/2 P/LPVs, non-BRCA P/LPVs showed a significantly low incidence of NCCN criteria listed family history, second primary cancer, and different molecular subtypes.<h4>Conclusions</h4>Desai's criteria might be a more appropriate genetic testing strategy for Chinese BC patients.